NCT06405490
- Conditions
- Advanced Cancer, Cadonilimab, Capecitabine, +5 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Clinical trial condition
Nanoliposomal Irinotecan
Explore clinical trials studying Nanoliposomal Irinotecan. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study